Clinical Trial Update: Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 clinical trial evaluating [177Lu]Lu-BQ7876 for targeting PSMA in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [177Lu]Lu-BQ7876

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Prostate Cancers | Phase 1 | Status: COMPLETED